News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Angel Biotechnology Ltd to Sell Cramlington Facility, Concentrate Output at Pentlands
June 27, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON (Thomson Financial) - Angel Biotechnology Holdings PLC said, following the increased cost burden at its Cramlington facility near Newcastle, it has decided to close and sell it and concentrate production at its Pentlands, Edinburgh, facility.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
Europe
MORE ON THIS TOPIC
Layoff Tracker
Gilead laying off vast majority of Arcellx employees
May 8, 2026
·
51 min read
·
BioSpace Editorial Staff
Earnings
Gilead sets blockbuster bar for Yeztugo’s first full year on the market
May 8, 2026
·
2 min read
·
Tristan Manalac
Pipeline
Ascendis retreats to rare endocrinology wheelhouse as cancer plans falter
May 8, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
FDA pilots AI-informed one-day facility inspections
May 7, 2026
·
2 min read
·
Nick Paul Taylor